PMLiVE14d
Roche’s Genentech granted FDA approval for TNKase in acute ischaemic stroke
Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in acute ischaemic stroke (AIS). The drug, which has been authorised for use in ...
Business Wire12d
F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Technology Activities, Innovation Programs, Initiatives, Partnership, Investments & Acquisition Network Map ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into ...
FiercePharma15d
Roche gains label expansion for heart attack medicine TNKase to treat acute ischemic stroke
Monday, the Roche subsidiary added a second stroke treatment to its repertoire, gaining an FDA endorsement for TNKase (tenecteplase). The tissue plasminogen activator, clot-dissolving ...
app.com5d
Why La Roche-Posay is pulling this acne treatment, and why you shouldn't use it
Here's why La Roche-Posay is pulling its Effaclar Duo Acne Spot Treatment from retail shelves. La Roche-Posay is a brand under the L'Oreal Group umbrella. A La Roche-Posay spokesperson confirmed ...
ABC News5d
La Roche-Posay, Proactiv, Walgreens skin care products voluntarily recalled over potentially cancer-causing chemical
The products are being recalled by the FDA for possible "benzene contamination." Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to ...
Yahoo Finance16d
F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Accelerators, Incubators, and Innovation Programs
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering. The report provides ...
Finanznachrichten11d
F. Hoffmann-La Roche Ltd: Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard's Enterprise Research Campus in Allston
Roche Global Media Relations Phone: +41 61 688 8888 / e-mail: [email protected] Hans Trees, PhD Phone: +41 79 407 72 58 Sileia Urech Phone: +41 79 935 81 48 ...
pharmaphorum1d
A history of Roche
We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...
CNN5d
Some La Roche-Posay, Proactiv and Walgreens acne treatments recalled due to benzene levels
Proactiv Skin Smoothing Exfoliator and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The full list and lot numbers was posted online Tuesday. “Even with daily use of these products for ...
Finanznachrichten26d
F. Hoffmann-La Roche Ltd: Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche Global Media Relations Phone: +41 61 688 8888 / e-mail: [email protected] Hans Trees, PhD Phone: +41 79 407 72 58 Sileia Urech Phone: +41 79 935 81 48 ...
The Harvard Crimson9d
Biotech Giant Roche Launches Innovation Center on Harvard’s Allston Research Campus
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an Innovation Center on Harvard’s Enterprise Research Campus in Allston.
Yahoo Finance14d
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults
Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke (AIS ...